Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4 SGD | +3.90% | +3.90% | -13.98% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 131.9 | 189 | 165.1 | 173.4 | 180.3 | 267.1 |
Enterprise Value (EV) 1 | 104.3 | 167.6 | 149.7 | 160.2 | 172.9 | 260.3 |
P/E ratio | 15.7 x | 25.2 x | 35 x | 25.2 x | 14.2 x | 20.6 x |
Yield | 6.12% | 2.25% | 2.67% | 3.33% | 4.95% | 3.46% |
Capitalization / Revenue | 3.26 x | 4.41 x | 4.54 x | 4.28 x | 2.86 x | 3.82 x |
EV / Revenue | 2.58 x | 3.91 x | 4.12 x | 3.96 x | 2.75 x | 3.72 x |
EV / EBITDA | 8.52 x | 13.6 x | 17 x | 15.6 x | 8.85 x | 13.4 x |
EV / FCF | 12.9 x | 19.6 x | 26 x | 18.4 x | 13.8 x | 29.7 x |
FCF Yield | 7.74% | 5.1% | 3.85% | 5.44% | 7.24% | 3.36% |
Price to Book | 1.97 x | 2.97 x | 2.32 x | 2.52 x | 2.26 x | 3.31 x |
Nbr of stocks (in thousands) | 517,096 | 532,349 | 550,299 | 550,349 | 572,230 | 574,474 |
Reference price 2 | 0.2550 | 0.3550 | 0.3000 | 0.3150 | 0.3150 | 0.4650 |
Announcement Date | 4/8/19 | 4/14/20 | 4/5/21 | 4/6/22 | 4/4/23 | 2/22/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 40.44 | 42.87 | 36.33 | 40.47 | 62.95 | 69.99 |
EBITDA 1 | 12.24 | 12.31 | 8.822 | 10.26 | 19.54 | 19.49 |
EBIT 1 | 10.71 | 10.71 | 7.144 | 8.64 | 17.84 | 17.49 |
Operating Margin | 26.48% | 24.97% | 19.67% | 21.35% | 28.34% | 24.99% |
Earnings before Tax (EBT) 1 | 11.19 | 9.905 | 6.506 | 9.086 | 16.78 | 17.31 |
Net income 1 | 8.407 | 7.465 | 4.69 | 6.905 | 12.52 | 12.96 |
Net margin | 20.79% | 17.41% | 12.91% | 17.06% | 19.89% | 18.52% |
EPS 2 | 0.0163 | 0.0141 | 0.008566 | 0.0125 | 0.0222 | 0.0226 |
Free Cash Flow 1 | 8.075 | 8.553 | 5.765 | 8.711 | 12.52 | 8.755 |
FCF margin | 19.97% | 19.95% | 15.87% | 21.53% | 19.89% | 12.51% |
FCF Conversion (EBITDA) | 65.98% | 69.48% | 65.34% | 84.94% | 64.06% | 44.92% |
FCF Conversion (Net income) | 96.05% | 114.58% | 122.91% | 126.15% | 99.99% | 67.54% |
Dividend per Share 2 | 0.0156 | 0.008000 | 0.008000 | 0.0105 | 0.0156 | 0.0161 |
Announcement Date | 4/8/19 | 4/14/20 | 4/5/21 | 4/6/22 | 4/4/23 | 2/22/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 27.6 | 21.4 | 15.4 | 13.1 | 7.38 | 6.84 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 8.07 | 8.55 | 5.76 | 8.71 | 12.5 | 8.75 |
ROE (net income / shareholders' equity) | 13% | 11% | 6.56% | 9.76% | 16.9% | 16.1% |
ROA (Net income/ Total Assets) | 9.22% | 9% | 5.46% | 6.13% | 11.3% | 10.1% |
Assets 1 | 91.16 | 82.97 | 85.95 | 112.6 | 111.1 | 128.9 |
Book Value Per Share 2 | 0.1300 | 0.1200 | 0.1300 | 0.1200 | 0.1400 | 0.1400 |
Cash Flow per Share 2 | 0.0500 | 0.0500 | 0.0400 | 0.0400 | 0.0400 | 0.0300 |
Capex 1 | 0.88 | 1.36 | 2.31 | 0.73 | 5.71 | 3.42 |
Capex / Sales | 2.19% | 3.17% | 6.37% | 1.81% | 9.07% | 4.88% |
Announcement Date | 4/8/19 | 4/14/20 | 4/5/21 | 4/6/22 | 4/4/23 | 2/22/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-13.98% | 169M | |
-17.07% | 16.85B | |
+3.60% | 12.34B | |
+5.64% | 11.77B | |
+4.83% | 10.28B | |
+25.36% | 8.38B | |
-0.68% | 7.88B | |
+22.18% | 7.29B | |
+5.77% | 6.75B | |
+52.00% | 4.69B |
- Stock Market
- Equities
- 40T Stock
- Financials ISEC Healthcare Ltd.